Harm reduction conference calls for political leadership to reform drugs policy
With EACS release, all international HIV treatment guidelines agree on when to start – for the first time since 2006
Tenofovir alafenamide single-tablet regimen shows good efficacy with improved kidney and bone safety
When will Europe get PrEP?
Can dolutegravir dual therapy or monotherapy produce and maintain HIV suppression?
The majority of migrants living with HIV in Europe may have acquired HIV in their new country
Benefits of early HIV treatment are clear, but issues raised by START and D:A:D remain unresolved
Needle and syringe exchanges need to adapt to meet the needs of people who inject steroids and image-enhancing drugs
Newest MDR-TB drug prices could fall by up to 95% through generic production
